Diabetes Devices Market Profit-Sources Analysis Report 2022-2031

Diabetes Devices Market Outlook 2031

The global diabetes devices market was valued at US$ 50.5 Bn in 2021
The global market is projected to grow at a CAGR of 6.0% from 2022 to 2031
The global diabetes devices market is anticipated to reach more than US$ 90.2 Bn by 2031

Request a Sample Report PDF: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14

Diabetes Devices Market Introduction

Diabetes is a global issue affecting millions of people every year. In the last decade, type 1 diabetes has been one of the major healthcare concerns across the world. Countries such as the U.S., China, U.K, and Germany have witnessed increasing rate of type 1 diabetes incidence. Type 1 diabetes is a form of autoimmune disease that occurs in children and adults, in which the pancreas stops producing insulin. Surge in incidence of type 1 diabetes among children is one of the major healthcare concerns. According to IDF, in 2015, Europe had 140,000 children (0-14 years) with type-1 diabetes, and 21,600 new cases are diagnosed every year. Type-1 diabetes patients primarily use insulin pen or insulin pump. Insulin pumps are more expensive than other insulin delivery devices. However, according to diabetes devices market trends, adoption of insulin pumps is increasing at a steady pace in developing and developed countries.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=14

Impact of COVID-19 on Diabetes Devices Market

The COVID-19 pandemic has had a negative effect on the diabetes devices market. The pandemic resulted in stock market turbulence, stringent border controls, and countrywide lockdowns, all taking their toll on various sectors. The pandemic has significantly strained hospital resources, including medical equipment and healthcare professionals. The supply chain of diabetes devices has been hampered, which has negatively affected the diabetes device market. However, diabetes is a chronic disease, and governments have sought to maintain regular supply of diabetes devices. A large population worked from home during the lockdown, and numerous patients used remote monitoring devices for diabetics. People were more focused on their diet to control diabetes naturally by regulating the food. These factors hampered the diabetes devices market.

Read Report Overview: https://www.transparencymarketresearch.com/diabetes-devices-market.html

Availability of Diabetes Tracker Devices with Advanced Sensors Fueling Glucose Monitoring Devices Segment

In terms of product type, the global diabetes devices market has been classified into glucose monitoring devices, insulin delivery devices, diabetes monitoring software, and artificial pancreas systems. The glucose monitoring devices segment has been segregated into self-monitoring blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring meters. The insulin delivery devices market segment has been split into insulin syringes, insulin pens, and insulin pumps. The glucose monitoring devices segment dominated the global diabetes devices market in 2021. The trend is projected to continue during the forecast period. Wide availability of diabetes tracker devices with advanced sensors for the detection of blood sugar levels is a major driver of the segment. Moreover, usage of wireless technology in continuous glucose monitoring (CGM) for transmitting glucose readings collected from the interstitial fluid between the patient's skin cells has become an important tool for diabetes monitoring devices.

High Prevalence of Type 2 and 1 Diabetes Bolstering Hospital Pharmacies Segment

Based on distribution channel, the global diabetes devices market has been divided into hospital pharmacies, retail pharmacies, online pharmacies, and diabetes clinics/centers. Hospital pharmacies is projected to be a highly attractive segment during the forecast period. High prevalence of type 2 and 1 diabetes is anticipated to increase hospital visits. Furthermore, the prevalence of diabetes among hospitalized patients is a major factor that drives the demand for diabetes devices at hospital pharmacies. The hospital pharmacies segment is likely to dominate the diabetes devices market during the forecast period. Increase in investment in R&D and a promising pipeline of artificial pancreas systems are anticipated to fuel the hospital pharmacies segment.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=14

Regional Outlook of Global Diabetes Devices Market

North America accounted for a major share of the global diabetes devices market in 2021. This is ascribed to large diabetes population, higher awareness, and significant healthcare spending in the overall national budget, early availability of advanced technologies, and higher penetration of healthcare services across the country. The U.S. is a major market for diabetes devices in North America. Factors such as the aging population, highly structured health care industry, and availability of well-defined reimbursement policies from public and private health insurance firms augment the diabetes devices market in the U.S. A report published in 2022 stated that the U.S. accounted for 37.3 million people who have diabetes, which is 11.3% of the population of the country. Around 28.7 million people have been diagnosed with diabetes. Among these, 8.5 million people who have diabetes have not been diagnosed and do not know they have it. Diabetes is the leading cause of kidney failure, blindness, and amputations in the U.S.

The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to rise in the prevalence of infectious diseases. Increase in the geriatric population, surge in healthcare expenditure, and rise in patient awareness about diabetes devices are fueling the market in the region. Countries such as China and India are expected to dominate the diabetes devices market in the region in the next few years. Asia Pacific is a relatively untapped market than developed regions. Hence, the region presents better growth opportunities in the diabetes devices market. China and India are the most populous countries in the world, and have the maximum number of diabetes patients. According to the International Diabetes Federation 2017, China has the largest number of people with diabetes aged between 20 and 79 years.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=14

Analysis of Key Players in Global Diabetes Devices Market

The diabetes devices market report includes vital information about leading players in the global market. Companies are adopting product launches, divestiture, merger & acquisition, and partnership strategies to enhance their market share. Medtronic, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Tandem Diabetes Care, Inc., Abbott Laboratories, Cellnovo, Insulet Corporation, LifeScan, Inc., and Owen Mumford Ltd. are the prominent players operating in the global market.

Key Developments in Global Diabetes Devices Market

In May 2022, Labcorp announced the launch of the at-home collection device Labcorp OnDemand, which measures hemoglobin A1c (HbA1c) from a small blood sample. The Labcorp OnDemand Diabetes Risk test uses dried blood technology to provide average blood sugar levels over time. With a prick of the finger and a few drops of blood, consumers can proactively monitor their health status on a regular basis from the comfort of their homes.

In January 2020, Tandem Diabetes Care, Inc. launched a slim X2 insulin pump with Control-IQ technology. The device comes with an advanced hybrid-closed loop feature designed to help increase time in range (70-180 mg/dL).

In May 2019, Roche Diabetes Care India launched Accu-Chek, a diabetes blood monitoring device, and the 'mySugr' app aimed at the betterment of people with diabetes

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=14

Each of these players has been profiled in the diabetes devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.